Navigation Links
CSUCI Receives $1.7 Million Grant for Stem Cell Research Program
Date:3/25/2009

CAMARILLO, Calif., March 25 /PRNewswire/ -- Dr. Ching-Hua Wang, Chair of Biology, Geology and Nursing, and Director of the MS Biotechnology and Bioinformatics Program at California State University Channel Islands, was recently awarded a grant of $1,733,406 from the California Institute for Regenerative Medicine (CIRM) as a part of their Bridges to Stem Cell Research program. CSUCI was one of 11 universities statewide to receive funding from the program.

"We are thrilled to have been awarded one of the CIRM grants. These grants are critically important to the future of regenerative medicine in California. Without personnel trained to carry out this research, the stem cell research field would not move as quickly as we would like," stated Dr. Wang.

The grant will fund both comprehensive lecture and laboratory courses designed to train students in stem cell research, internship placement, and completion of a new Emphasis in Stem Cell Technology and Laboratory Management within the MS Biotechnology and Bioinformatics degree program at CSUCI. The new degree program will provide students with the necessary expertise to enter the workforce in a rapidly expanding and technologically advanced field. One of the courses funded by the grant is a general education course on stem cell technology to be developed by faculty at CSUCI in collaboration with faculty from community colleges in Ventura County.

Robert Klein, chairman of the CIRM governing board stated, "Training young people is critical to our mission of developing new therapies. As California's stem cell industry continues to grow, the state will face a critical shortage for biomedical laboratory workers trained in state-of-the-art techniques required by stem cell research labs." Klein goes on to say that the Bridges to Stem Cell Research program trains students to fill these necessary positions in the industry.

CIRM was established in 2005 with the passage of the California Stem Cell Research and Cures Act. The mission of CIRM is to support and advance stem cell research and regenerative medicine under the highest ethical and medical standards for the discovery and development of cures, therapies, diagnostics and research technologies to relieve human suffering from chronic disease and injury. The CIRM governing board has approved more than $693 million in grants, making it the largest source of funding for embryonic stem cell research in the world.

For further information about the CIRM grant or the MS Biotechnology and Bioinformatics degree program at CSUCI, contact Dr. Ching-Hua Wang at 805-437-8870 or ching-hua.wang@csuci.edu.

For media inquiries contact Nancy Covarrubias Gill, Director of Communication & Marketing at CSUCI, 805-437-8456 or nancy.gill@csuci.edu.

CSU Channel Islands is accredited by the Accrediting Commission for Senior Colleges and Universities of the Western Association of Schools and Colleges.

CSUCI Mission Statement

Placing students at the center of the educational experience, California State University Channel Islands provides undergraduate and graduate education that facilitates learning within and across disciplines through integrative approaches, emphasizes experiential and service learning, and graduates students with multicultural and international perspectives.

Available Topic Expert(s): For information on the listed expert(s), click appropriate link.

Ching-Hua Wang

https://profnet.prnewswire.com/Subscriber/ExpertProfile.aspx?ei=87147


'/>"/>
SOURCE CSU Channel Islands
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Lake Elsinore Family Caregiver Receives Free Power Wheelchair From The SCOOTER Store
2. DaVita Receives Civil Complaint
3. Ranbaxy Receives Tentative Approval to Manufacture and Market Galantamine Tablets on an Exclusive Basis
4. Watson Receives First FDA Approval for Manufacturing Product at Its Goa, India Facility
5. Edwards Lifesciences Receives CE Mark for Edwards SAPIEN Transcatheter Heart Valve
6. PainCare Receives $14.4 Million in Cash From Completed Sale of South Florida Ambulatory Surgery Centers
7. UT Southwesterns obesity research receives $22 million NIH Roadmap grant
8. Temple Emergency Medicine receives $1.8M to find best MRSA treatment
9. Prime Therapeutics Receives TIPPS Certification
10. Bioniche Receives $2 Million Government Grant For Market Development Related to its E. coli O157:H7 Cattle Vaccine
11. UCLA receives $22.5 million to explore the fundamental biology of mental disorders
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2017)... ... 28, 2017 , ... Semrock’s highly popular SearchLight Spectra Viewer ... resource for fluorescence microscopists and optical system designers, enabling The Right Solution, Right ... the globe, SearchLight has become a tremendously popular tool for the fluorescence imaging ...
(Date:4/27/2017)... ... April 27, 2017 , ... Thinksport, the leaders in safe, ... award-winning sunscreen they’ve used the same scientific approach to solving smelly, sweaty athletes, ... the aisles that contain harmful chemicals that should be put nowhere near your ...
(Date:4/27/2017)... ... April 27, 2017 , ... Offering the purest product of its ... times purer and more potent than the market has seen before. Swissx uses proprietary ... well as a patented chromatography process for extraction, to produce its CBD oil--maximizing its ...
(Date:4/26/2017)... , ... April 26, 2017 , ... Journal of ... It can have severe consequences to overall dental health, including complications with speech, eating, ... turn to dental implants to replace lost teeth. As the number of tooth replacements ...
(Date:4/26/2017)... ... April 26, 2017 , ... The ... Excellence upon National Registry of Emergency Medical Technicians and welcomes this ... said Dr. Jan G. West, Ph.D. , CEO & Organizational Psychologist at ...
Breaking Medicine News(10 mins):
(Date:4/24/2017)... England , April 24, 2017 ... development, today announced the addition of a major ... ,Validated In-situ Plate Seeding,). The VIPS has been ... and 384 well microplates as part of the ... system offers a simple and more reliable solution ...
(Date:4/20/2017)... 2017 Research and Markets has ... and Market Prospects: Addressing Production Complexities Through Risk Management ... ... Biosimilar Pipeline and Market Prospects: Overcoming Production Complexities Through ... assessment of the current trends in the global biosimilars ...
(Date:4/20/2017)... -- AbbVie (NYSE: ABBV), a global biopharmaceutical company, today ... C virus (HCV) infected patients with genotype 1, ... (Child-Pugh A) achieved sustained virologic response at 12 ... pan-genotypic regimen of glecaprevir/pibrentasvir (G/P). These high SVR ... of G/P treatment without ribavirin. Patients with specific ...
Breaking Medicine Technology: